Literature DB >> 25219111

Long-term prophylaxis with C1-inhibitor concentrate in patients with hereditary angioedema.

M Pedrosa, T Lobera, C Panizo, J Jurado, T Caballero.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 25219111

Source DB:  PubMed          Journal:  J Investig Allergol Clin Immunol        ISSN： 1018-9068            Impact factor:   4.333


× No keyword cloud information.
  5 in total

1.  Breakthrough attacks in patients with hereditary angioedema receiving long-term prophylaxis are responsive to icatibant: findings from the Icatibant Outcome Survey.

Authors:  Werner Aberer; Marcus Maurer; Laurence Bouillet; Andrea Zanichelli; Teresa Caballero; Hilary J Longhurst; Amandine Perrin; Irmgard Andresen
Journal:  Allergy Asthma Clin Immunol       Date:  2017-07-05       Impact factor: 3.406

2.  Efficacy and safety of an intravenous C1-inhibitor concentrate for long-term prophylaxis in hereditary angioedema.

Authors:  Timothy Craig; Ralph Shapiro; Arthur Vegh; James W Baker; Jonathan A Bernstein; Paula Busse; Markus Magerl; Inmaculada Martinez-Saguer; Marc A Riedl; William Lumry; Debora Williams-Herman; Jonathan Edelman; Henrike Feuersenger; Thomas Machnig; Mikhail Rojavin
Journal:  Allergy Rhinol (Providence)       Date:  2017-03-01

3.  Outcomes of long term treatments of type I hereditary angioedema in a Turkish family.

Authors:  Gulsen Akoglu; Belgin Kesim; Gokhan Yildiz; Ahmet Metin
Journal:  An Bras Dermatol       Date:  2017 Sep-Oct       Impact factor: 1.896

Review 4.  Management of hereditary angioedema in pregnant women: a review.

Authors:  Teresa Caballero; Julio Canabal; Daniela Rivero-Paparoni; Rosario Cabañas
Journal:  Int J Womens Health       Date:  2014-09-09

5.  Use of a C1 Inhibitor Concentrate in Adults ≥65 Years of Age with Hereditary Angioedema: Findings from the International Berinert® (C1-INH) Registry.

Authors:  Anette Bygum; Inmaculada Martinez-Saguer; Murat Bas; Jeffrey Rosch; Jonathan Edelman; Mikhail Rojavin; Debora Williams-Herman
Journal:  Drugs Aging       Date:  2016-11       Impact factor: 3.923
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.